Platform Wealth Management LLC Invests $6.85 Million in CVS Health Corporation $CVS

Platform Wealth Management LLC bought a new position in CVS Health Corporation (NYSE:CVS) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 86,350 shares of the pharmacy operator’s stock, valued at approximately $6,853,000. CVS Health comprises about 1.8% of Platform Wealth Management LLC’s investment portfolio, making the stock its 15th biggest holding.

Other large investors have also recently made changes to their positions in the company. Kingsview Wealth Management LLC increased its holdings in shares of CVS Health by 316.2% in the third quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator’s stock worth $7,873,000 after purchasing an additional 79,340 shares during the last quarter. Assetmark Inc. grew its position in CVS Health by 12.5% in the third quarter. Assetmark Inc. now owns 678,558 shares of the pharmacy operator’s stock worth $51,156,000 after acquiring an additional 75,603 shares in the last quarter. Intech Investment Management LLC grew its position in CVS Health by 50.3% in the third quarter. Intech Investment Management LLC now owns 86,564 shares of the pharmacy operator’s stock worth $6,526,000 after acquiring an additional 28,953 shares in the last quarter. Hamlin Capital Management LLC purchased a new position in CVS Health in the fourth quarter worth about $160,844,000. Finally, Cresset Asset Management LLC grew its position in CVS Health by 56.8% in the third quarter. Cresset Asset Management LLC now owns 35,481 shares of the pharmacy operator’s stock worth $2,675,000 after acquiring an additional 12,849 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on CVS. Argus lifted their price target on CVS Health from $90.00 to $104.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. UBS Group lifted their price target on CVS Health from $97.00 to $100.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. HSBC lifted their price target on CVS Health from $83.00 to $85.00 and gave the stock a “hold” rating in a research report on Tuesday, May 5th. DA Davidson lifted their price target on CVS Health from $80.00 to $100.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Finally, Royal Bank Of Canada lifted their price target on CVS Health from $93.00 to $107.00 and gave the stock an “outperform” rating in a research report on Thursday, May 7th. Twenty-two investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $99.68.

Insider Buying and Selling

In related news, EVP Tilak Mandadi sold 69,551 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the completion of the sale, the executive vice president owned 10,133 shares in the company, valued at approximately $907,714.14. The trade was a 87.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Larry Robbins sold 370,462 shares of the business’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $93.45, for a total value of $34,619,673.90. Following the completion of the sale, the director owned 4,824,799 shares of the company’s stock, valued at $450,877,466.55. The trade was a 7.13% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 3,441,551 shares of company stock valued at $323,703,977 in the last quarter. 0.85% of the stock is owned by company insiders.

CVS Health Trading Up 2.4%

CVS opened at $91.61 on Thursday. The stock has a market cap of $116.89 billion, a price-to-earnings ratio of 40.36, a P/E/G ratio of 0.88 and a beta of 0.62. The stock’s 50 day moving average price is $83.21 and its 200-day moving average price is $79.79. CVS Health Corporation has a one year low of $58.50 and a one year high of $98.43. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.66 and a current ratio of 0.87.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, beating analysts’ consensus estimates of $2.21 by $0.36. The firm had revenue of $100.43 billion for the quarter, compared to analysts’ expectations of $94.99 billion. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The company’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.25 earnings per share. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, equities analysts forecast that CVS Health Corporation will post 7.44 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, May 4th. Investors of record on Thursday, April 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, April 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. CVS Health’s payout ratio is presently 117.18%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.